|
US3753357A
(en)
|
1970-12-14 |
1973-08-21 |
Ovitron Res Corp |
Method and apparatus for the preservation of cells and tissues
|
|
US4199022A
(en)
|
1978-12-08 |
1980-04-22 |
The United States Of America As Represented By The Department Of Energy |
Method of freezing living cells and tissues with improved subsequent survival
|
|
US4559298A
(en)
|
1982-11-23 |
1985-12-17 |
American National Red Cross |
Cryopreservation of biological materials in a non-frozen or vitreous state
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
|
IL86278A
(en)
*
|
1988-05-04 |
2003-06-24 |
Yeda Res & Dev |
Endowing cells with antibody specificity using chimeric t cell receptor
|
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
|
US5858358A
(en)
|
1992-04-07 |
1999-01-12 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for selectively stimulating proliferation of T cells
|
|
US6905680B2
(en)
|
1988-11-23 |
2005-06-14 |
Genetics Institute, Inc. |
Methods of treating HIV infected subjects
|
|
US6352694B1
(en)
|
1994-06-03 |
2002-03-05 |
Genetics Institute, Inc. |
Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
|
|
US6534055B1
(en)
|
1988-11-23 |
2003-03-18 |
Genetics Institute, Inc. |
Methods for selectively stimulating proliferation of T cells
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5399346A
(en)
|
1989-06-14 |
1995-03-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Gene therapy
|
|
US5585362A
(en)
|
1989-08-22 |
1996-12-17 |
The Regents Of The University Of Michigan |
Adenovirus vectors for gene therapy
|
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
|
US5633425A
(en)
|
1990-08-29 |
1997-05-27 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
|
US5625126A
(en)
|
1990-08-29 |
1997-04-29 |
Genpharm International, Inc. |
Transgenic non-human animals for producing heterologous antibodies
|
|
ES2108048T3
(es)
|
1990-08-29 |
1997-12-16 |
Genpharm Int |
Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
|
|
US5545806A
(en)
|
1990-08-29 |
1996-08-13 |
Genpharm International, Inc. |
Ransgenic non-human animals for producing heterologous antibodies
|
|
US5661016A
(en)
|
1990-08-29 |
1997-08-26 |
Genpharm International Inc. |
Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
|
|
DE69129154T2
(de)
|
1990-12-03 |
1998-08-20 |
Genentech, Inc., South San Francisco, Calif. |
Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US5350674A
(en)
|
1992-09-04 |
1994-09-27 |
Becton, Dickinson And Company |
Intrinsic factor - horse peroxidase conjugates and a method for increasing the stability thereof
|
|
GB9221657D0
(en)
|
1992-10-15 |
1992-11-25 |
Scotgen Ltd |
Recombinant bispecific antibodies
|
|
US5585358A
(en)
|
1993-07-06 |
1996-12-17 |
Yissum Research Development Corporation Of The Hebrew University Of Jerusalem |
Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
|
|
US7175843B2
(en)
|
1994-06-03 |
2007-02-13 |
Genetics Institute, Llc |
Methods for selectively stimulating proliferation of T cells
|
|
US6692964B1
(en)
|
1995-05-04 |
2004-02-17 |
The United States Of America As Represented By The Secretary Of The Navy |
Methods for transfecting T cells
|
|
US7067318B2
(en)
|
1995-06-07 |
2006-06-27 |
The Regents Of The University Of Michigan |
Methods for transfecting T cells
|
|
AU6353596A
(en)
|
1995-06-30 |
1997-02-05 |
Kobenhavns Universitet |
Recombinant antibodies from a phage display library, directed against a peptide-mhc complex
|
|
DE19544393A1
(de)
|
1995-11-15 |
1997-05-22 |
Hoechst Schering Agrevo Gmbh |
Synergistische herbizide Mischungen
|
|
WO2001029058A1
(en)
|
1999-10-15 |
2001-04-26 |
University Of Massachusetts |
Rna interference pathway genes as tools for targeted genetic interference
|
|
US6326193B1
(en)
|
1999-11-05 |
2001-12-04 |
Cambria Biosciences, Llc |
Insect control agent
|
|
WO2001044463A1
(en)
|
1999-12-15 |
2001-06-21 |
Genentech, Inc. |
Shotgun scanning, a combinatorial method for mapping functional protein epitopes
|
|
US6867041B2
(en)
|
2000-02-24 |
2005-03-15 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
US7572631B2
(en)
|
2000-02-24 |
2009-08-11 |
Invitrogen Corporation |
Activation and expansion of T cells
|
|
US6797514B2
(en)
|
2000-02-24 |
2004-09-28 |
Xcyte Therapies, Inc. |
Simultaneous stimulation and concentration of cells
|
|
AU4328801A
(en)
|
2000-02-24 |
2001-09-03 |
Xcyte Therapies Inc |
Simultaneous stimulation and concentration of cells
|
|
ES2637801T3
(es)
|
2000-04-11 |
2017-10-17 |
Genentech, Inc. |
Anticuerpos multivalentes y usos de los mismos
|
|
AU2001275474A1
(en)
|
2000-06-12 |
2001-12-24 |
Akkadix Corporation |
Materials and methods for the control of nematodes
|
|
CA2425862C
(en)
|
2000-11-07 |
2013-01-22 |
City Of Hope |
Cd19-specific redirected immune cells
|
|
US7771951B2
(en)
|
2001-12-03 |
2010-08-10 |
Amgen Fremont Inc. |
Antibody categorization based on binding characteristics
|
|
US6992176B2
(en)
|
2002-02-13 |
2006-01-31 |
Technion Research & Development Foundation Ltd. |
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
JP4753578B2
(ja)
|
2002-06-03 |
2011-08-24 |
ジェネンテック， インコーポレイテッド |
合成抗体ファージライブラリー
|
|
US20050079574A1
(en)
|
2003-01-16 |
2005-04-14 |
Genentech, Inc. |
Synthetic antibody phage libraries
|
|
CA2523716C
(en)
|
2003-05-31 |
2014-11-25 |
Micromet Ag |
Human anti-human cd3 binding molecules
|
|
US7785903B2
(en)
|
2004-04-09 |
2010-08-31 |
Genentech, Inc. |
Variable domain library and uses
|
|
US20060034850A1
(en)
|
2004-05-27 |
2006-02-16 |
Weidanz Jon A |
Antibodies as T cell receptor mimics, methods of production and uses thereof
|
|
TWI671403B
(zh)
|
2005-03-31 |
2019-09-11 |
中外製藥股份有限公司 |
控制組裝之多肽的製造方法
|
|
AU2006262232A1
(en)
|
2005-06-20 |
2007-01-04 |
Medarex, Inc. |
CD19 antibodies and their uses
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
AU2006293420B2
(en)
|
2005-09-22 |
2011-06-30 |
Irun R. Cohen |
Immunogenic fragments of T-cell receptor constant domains and peptides derived therefrom
|
|
EP1957531B1
(en)
|
2005-11-07 |
2016-04-13 |
Genentech, Inc. |
Binding polypeptides with diversified and consensus vh/vl hypervariable sequences
|
|
EP1973951A2
(en)
|
2005-12-02 |
2008-10-01 |
Genentech, Inc. |
Binding polypeptides with restricted diversity sequences
|
|
PL2013236T3
(pl)
|
2006-04-28 |
2015-12-31 |
Delenex Therapeutics Ag |
Przeciwciała łączące się z zewnątrzkomórkową domeną receptora kinazy tyrozynowej ALK
|
|
CA2651174A1
(en)
|
2006-05-03 |
2007-11-15 |
Government Of The United States Of America, Represented By The Secretary , Department Of Health And Human Services |
Chimeric t cell receptors and related materials and methods of use
|
|
WO2007134050A2
(en)
|
2006-05-09 |
2007-11-22 |
Genentech, Inc. |
Binding polypeptides with optimized scaffolds
|
|
WO2007143104A2
(en)
|
2006-06-01 |
2007-12-13 |
Receptor Logic, Ltd. |
Antibodies as t cell receptor mimics, methods of production and uses thereof
|
|
AU2007294575B2
(en)
|
2006-09-08 |
2013-06-27 |
Viela Bio, Inc. |
Humanized anti-CD19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
|
|
CA2685675C
(en)
|
2007-05-01 |
2016-02-16 |
Research Development Foundation |
Immunoglobulin fc libraries
|
|
AR066476A1
(es)
|
2007-05-08 |
2009-08-19 |
Genentech Inc |
Anticuerpos anti-muc16 disenados con cisteina y conjugaods de anticuerpos y farmacos
|
|
CN100592373C
(zh)
|
2007-05-25 |
2010-02-24 |
群康科技(深圳)有限公司 |
液晶显示面板驱动装置及其驱动方法
|
|
BRPI0914780B8
(pt)
|
2008-06-25 |
2022-07-05 |
Athenix Corp |
Molécula de ácido nucleico isolada, vetor, célula hospedeira, composição, e métodos para o controle de uma população de pragas, matar uma praga proteção de uma planta de uma praga e produção de um polipeptídeo com atividade pesticida
|
|
TWI580431B
(zh)
|
2008-08-19 |
2017-05-01 |
腫瘤療法 科學股份有限公司 |
Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
|
|
PE20100362A1
(es)
|
2008-10-30 |
2010-05-27 |
Irm Llc |
Derivados de purina que expanden las celulas madre hematopoyeticas
|
|
WO2010059543A1
(en)
|
2008-11-20 |
2010-05-27 |
Merck Sharp & Dohme Corp. |
Generation and characterization of anti-notch antibodies for therapeutic and diagnostic use
|
|
US20100153133A1
(en)
|
2008-12-16 |
2010-06-17 |
International Business Machines Corporation |
Generating Never-Event Cohorts from Patient Care Data
|
|
WO2010091637A1
(en)
|
2009-02-10 |
2010-08-19 |
Shenogen Pharma Group Ltd. |
Antibodies and methods for treating estrogen receptor-associated diseases
|
|
EP2258719A1
(en)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Multiple target T cell receptor
|
|
AU2010277561A1
(en)
|
2009-07-30 |
2012-02-09 |
Helmholtz-Zentrum Fur Infektionsforschung Gmbh |
Compositions for generating an antigen specific immune response
|
|
AU2010309438A1
(en)
|
2009-10-22 |
2012-06-07 |
Ricardo J. Moro |
Peptides that bind the alpha-fetoprotein (AFP) receptor and uses thereof
|
|
US9273283B2
(en)
|
2009-10-29 |
2016-03-01 |
The Trustees Of Dartmouth College |
Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
|
|
CA2793753C
(en)
|
2010-03-26 |
2018-06-05 |
Memorial Sloan-Kettering Cancer Center |
Antibodies to muc16 and methods of use thereof
|
|
WO2012050374A2
(en)
|
2010-10-13 |
2012-04-19 |
Innocell, Inc. |
Immunotherapy for solid tumors
|
|
US10239952B2
(en)
|
2011-04-01 |
2019-03-26 |
Memorial Sloan Kettering Cancer Center |
Anti-WT1/HLA bi-specific antibody
|
|
PH12013502043A1
(en)
|
2011-04-01 |
2013-12-16 |
Memorial Sloan Kettering Cancer Center |
T cell receptor-like antibodies specific for a wt1 peptide presented by hla-a2
|
|
US20130280220A1
(en)
*
|
2012-04-20 |
2013-10-24 |
Nabil Ahmed |
Chimeric antigen receptor for bispecific activation and targeting of t lymphocytes
|
|
CA2871417C
(en)
|
2012-04-23 |
2021-08-31 |
Genefrontier Corporation |
Anti-human cd69 antibody, and use thereof for medical purposes
|
|
CN103319595B
(zh)
|
2012-07-04 |
2016-12-28 |
中国药科大学 |
抗人afp单链抗体以及融合抗原肽的制备方法和应用
|
|
SG11201408787PA
(en)
|
2012-07-13 |
2015-01-29 |
Univ Pennsylvania |
Enhancing activity of car t cells by co-introducing a bispecific antibody
|
|
WO2014014796A1
(en)
|
2012-07-18 |
2014-01-23 |
Eli Lilly And Company |
Multi-specific igg-(fab)2 constructs containing t-cell receptor constant domains
|
|
AU2013312838B2
(en)
*
|
2012-09-04 |
2018-11-29 |
Cellectis |
Multi-chain chimeric antigen receptor and uses thereof
|
|
CN112458057A
(zh)
*
|
2012-10-02 |
2021-03-09 |
纪念斯隆-凯特琳癌症中心 |
用于免疫疗法的组合物和方法
|
|
CN102993305B
(zh)
|
2012-11-16 |
2015-05-13 |
上海赛伦生物技术有限公司 |
人源抗人表皮生长因子受体抗体及其编码基因与应用
|
|
US20160000893A1
(en)
|
2012-12-13 |
2016-01-07 |
University Of Virginia Patent Foundation |
Target peptides for ovarian cancer therapy and diagnostics
|
|
CN103965362B
(zh)
|
2013-02-06 |
2019-02-01 |
上海细胞治疗集团有限公司 |
一种可使t细胞趋向肿瘤部位的嵌合趋化因子受体
|
|
JPWO2014123165A1
(ja)
|
2013-02-06 |
2017-02-02 |
旭硝子株式会社 |
透明面材およびそれを用いた表示装置
|
|
EP2961831B1
(en)
|
2013-02-26 |
2020-06-10 |
Memorial Sloan Kettering Cancer Center |
Compositions and methods for immunotherapy
|
|
WO2014152878A2
(en)
|
2013-03-14 |
2014-09-25 |
Agrivida, Inc. |
Use of dimerization domains for temperature regulation of enzyme activity
|
|
US9657105B2
(en)
|
2013-03-15 |
2017-05-23 |
City Of Hope |
CD123-specific chimeric antigen receptor redirected T cells and methods of their use
|
|
WO2014153470A2
(en)
|
2013-03-21 |
2014-09-25 |
Sangamo Biosciences, Inc. |
Targeted disruption of t cell receptor genes using engineered zinc finger protein nucleases
|
|
KR101536668B1
(ko)
|
2013-06-18 |
2015-07-15 |
사회복지법인 삼성생명공익재단 |
인간 및 마우스 c-Met에 교차결합하는 항체 및 그의 용도
|
|
GB201313377D0
(en)
|
2013-07-26 |
2013-09-11 |
Adaptimmune Ltd |
T cell receptors
|
|
JP6543626B2
(ja)
|
2013-07-29 |
2019-07-10 |
ブルーバード バイオ， インコーポレイテッド |
多部分シグナル伝達タンパク質およびその使用
|
|
WO2015063069A1
(en)
|
2013-10-28 |
2015-05-07 |
Benjamin Felder |
Chimeric antigen receptors with antigen binding domains derived from gamma delta t cell receptors
|
|
AU2014346648A1
(en)
|
2013-11-07 |
2016-06-23 |
Eureka Therapeutics, Inc. |
Fc-enhanced anti-WT1/HLA antibody
|
|
JP6553069B2
(ja)
|
2013-11-07 |
2019-07-31 |
メモリアル スローン ケタリング キャンサー センター |
抗ｗｔ１／ｈｌａ二重特異性抗体
|
|
EA035266B1
(ru)
*
|
2014-02-28 |
2020-05-22 |
Икнос Сайенсиз Са |
Экспрессирующие конструкции и способы для отбора клеток-хозяев, экспрессирующих полипептиды
|
|
CN104087592B
(zh)
|
2014-05-13 |
2016-01-27 |
天津医科大学总医院 |
Afp158-166特异性tcr基因及其转基因t细胞及体外增殖方法及用途
|
|
WO2016042461A1
(en)
|
2014-09-15 |
2016-03-24 |
Molmed Spa |
Chimeric antigen receptors
|
|
WO2016071343A1
(en)
*
|
2014-11-03 |
2016-05-12 |
Immures S.R.L. |
T cell receptors
|
|
SG11201704550XA
(en)
|
2014-12-05 |
2017-07-28 |
Memorial Sloan Kettering Cancer Center |
Chimeric antigen receptors targeting fc receptor-like 5 and uses thereof
|
|
EP4310097A3
(en)
|
2014-12-05 |
2024-04-03 |
Memorial Sloan Kettering Cancer Center |
Chimeric antigen receptors targeting b-cell maturation antigen and uses thereof
|
|
KR20230159637A
(ko)
|
2014-12-05 |
2023-11-21 |
메모리얼 슬로안 케터링 캔서 센터 |
G-단백질 커플화 수용체를 표적화하는 항체 및 이의 사용 방법
|
|
PT3227339T
(pt)
|
2014-12-05 |
2022-01-14 |
Eureka Therapeutics Inc |
Recetores de antigénio quiméricos que têm como alvo o recetor 4 acoplado a proteína g e utilizações dos mesmos
|
|
CA2969877A1
(en)
|
2014-12-05 |
2016-06-09 |
Memorial Sloan-Kettering Cancer Center |
Antibodies targeting b-cell maturation antigen and methods of use
|
|
WO2016142768A1
(en)
|
2015-03-10 |
2016-09-15 |
Eureka Therapeutics, Inc. |
Ror2 antibody
|
|
EP4190817A1
(en)
|
2015-03-17 |
2023-06-07 |
Memorial Sloan Kettering Cancer Center |
Anti-muc16 antibodies and uses thereof
|
|
WO2016149578A1
(en)
|
2015-03-19 |
2016-09-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Dual specific anti-cd22-anti-cd19 chimeric antigen receptors
|
|
WO2016154047A2
(en)
|
2015-03-20 |
2016-09-29 |
Memorial Sloan-Kettering Cancer Center |
Monoclonal antigen-binding proteins to intracellular oncogene products
|
|
RU2021124437A
(ru)
|
2015-04-03 |
2021-09-29 |
Еурека Терапьютикс, Инк. |
Конструкции, направленные на комплексы пептида afp/mhc, и виды их использования
|
|
WO2016182957A1
(en)
|
2015-05-08 |
2016-11-17 |
Eureka Therapeutics, Inc. |
Constructs targeting hpv16-e7 peptide/mhc complexes and uses thereof
|
|
EP3297671A4
(en)
|
2015-05-18 |
2019-02-06 |
Eureka Therapeutics, Inc. |
ANTI-ROR1 ANTIBODY
|
|
US20180147271A1
(en)
|
2015-05-18 |
2018-05-31 |
Bluebird Bio, Inc. |
Anti-ror1 chimeric antigen receptors
|
|
MX2017014822A
(es)
*
|
2015-05-18 |
2018-04-30 |
Tcr2 Therapeutics Inc |
Composiciones y métodos para la reprogramación del tcr con proteínas de fusión.
|
|
EP3297673A4
(en)
|
2015-05-22 |
2019-05-08 |
Memorial Sloan-Kettering Cancer Center |
FOR A PRAME-PEPTIDE SPECIFIC T-CELL RECEPTOR-SIMILAR ANTIBODIES
|
|
NL2014935B1
(en)
|
2015-06-08 |
2017-02-03 |
Applied Immune Tech Ltd |
T cell receptor like antibodies having fine specificity.
|
|
SG10202110887PA
(en)
|
2015-06-09 |
2021-11-29 |
Memorial Sloan Kettering Cancer Center |
T cell receptor-like antibody agents specific for ebv latent membrane protein 2a peptide presented by human hla
|
|
WO2016199414A1
(en)
|
2015-06-12 |
2016-12-15 |
Minebea Co., Ltd. |
Load detector and load detection system
|
|
EP3313883B1
(en)
|
2015-06-23 |
2023-12-06 |
Memorial Sloan Kettering Cancer Center |
Novel pd-1 immune modulating agents
|
|
AU2016283133A1
(en)
|
2015-06-24 |
2018-01-04 |
Eureka Therapeutics, Inc. |
Constructs targeting NY-ESO-1 peptide/MHC complexes and uses thereof
|
|
US11059880B2
(en)
|
2015-06-30 |
2021-07-13 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Redirected cells with MHC chimeric receptors and methods of use in immunotherapy
|
|
US20200087400A1
(en)
|
2015-07-22 |
2020-03-19 |
Eureka Therapeutics, Inc. |
Constructs targeting psa peptide/mhc complexes and uses thereof
|
|
US11667691B2
(en)
*
|
2015-08-07 |
2023-06-06 |
Novartis Ag |
Treatment of cancer using chimeric CD3 receptor proteins
|
|
CN105384825B
(zh)
*
|
2015-08-11 |
2018-06-01 |
南京传奇生物科技有限公司 |
一种基于单域抗体的双特异性嵌合抗原受体及其应用
|
|
WO2017044699A1
(en)
|
2015-09-10 |
2017-03-16 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Anti-cd276 chimeric antigen receptors
|
|
MX2018003353A
(es)
|
2015-09-17 |
2018-09-17 |
Novartis Ag |
Terapias con celulas cart con una eficacia mejorada.
|
|
MX2018004515A
(es)
*
|
2015-10-13 |
2019-04-15 |
Eureka Therapeutics Inc |
Agentes de anticuerpo especificos para cd19 humano y usos de los mismos.
|
|
WO2017070608A1
(en)
|
2015-10-23 |
2017-04-27 |
Eureka Therapeutics, Inc. |
Antibody/t-cell receptor chimeric constructs and uses thereof
|
|
CN105331585A
(zh)
|
2015-11-13 |
2016-02-17 |
科济生物医药（上海）有限公司 |
携带pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞
|
|
BR112018011336A2
(pt)
|
2015-12-04 |
2018-12-04 |
Memorial Sloan-Kettering Cancer Center |
anticorpo anti-fcrl5 isolado ou um fragmento de ligação ao antígeno do mesmo, anticorpo scfv anti-fcrl5 isolado, anticorpo isolado ou porção de ligação ao antígeno do mesmo, composição, imunoconjugado, molécula biespecífica, ácido nucleico isolado, vetor de expressão, célula hospedeira, método para detectar fcrl5 em uma célula ou tecido inteiro, método para tratar câncer em um indivíduo, uso do anticorpo ou fragmento de ligação ao antígeno do mesmo, kit para tratar câncer
|
|
BR112018013914A2
(pt)
*
|
2016-01-08 |
2018-12-11 |
Univ California |
polipeptídeos heterodiméricos condicionalmente ativos e métodos de utilização deste
|
|
WO2017124001A2
(en)
|
2016-01-14 |
2017-07-20 |
Memorial Sloan-Kettering Cancer Center |
T cell receptor-like antibodies specific for foxp3-derived peptides
|
|
CA3032498A1
(en)
|
2016-08-02 |
2018-02-08 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
WO2018057967A2
(en)
|
2016-09-23 |
2018-03-29 |
Eureka Therapeutics, Inc. |
Constructs targeting hiv peptide/mhc complexes and uses thereof
|
|
MX2019003899A
(es)
|
2016-10-07 |
2019-08-14 |
Tcr2 Therapeutics Inc |
Composiciones y metodos para reprogramacion de receptores de linfocitos t mediante el uso de proteinas de fusion.
|
|
EP3544996A2
(en)
|
2016-11-22 |
2019-10-02 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
AU2017382902A1
(en)
|
2016-12-21 |
2019-07-18 |
TCR2 Therapeutics Inc. |
Engineered T cells for the treatment of cancer
|
|
EP3579877A4
(en)
|
2017-02-09 |
2020-12-09 |
The Regents of The University of California |
CHEMERIC T-LYMPHOCYTE ANTIGENIC RECEPTORS AND METHODS OF USE
|
|
CN110741016A
(zh)
*
|
2017-04-26 |
2020-01-31 |
优瑞科生物技术公司 |
嵌合抗体/t-细胞受体构筑体及其用途
|
|
MX420947B
(es)
|
2017-04-26 |
2025-02-10 |
Eureka Therapeutics Inc |
Constructos que reconocen específicamente glipicano 3 y usos de estos.
|
|
EP3638295A1
(en)
|
2017-06-13 |
2020-04-22 |
TCR2 Therapeutics Inc. |
Compositions and methods for tcr reprogramming using fusion proteins
|
|
CN112888709B
(zh)
|
2018-03-30 |
2024-10-29 |
优瑞科生物技术公司 |
标靶cd22的构建体和其用途
|
|
EP3806904A4
(en)
|
2018-06-18 |
2022-04-27 |
Eureka Therapeutics, Inc. |
PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA) TARGETED CONSTRUCTS AND USES THEREOF
|
|
EP4640698A3
(en)
|
2018-11-16 |
2026-02-25 |
Memorial Sloan Kettering Cancer Center |
Antibodies to mucin-16 and methods of use thereof
|
|
JP7675016B2
(ja)
|
2019-05-08 |
2025-05-12 |
メモリアル スローン ケタリング キャンサー センター |
ムチン－１６に対するヒト化抗体およびそれを使用する方法
|
|
CA3148646A1
(en)
|
2019-07-24 |
2021-01-28 |
Eureka Therapeutics, Inc. |
Cells expressing chimeric antigen receptors and chimeric stimulating receptors and uses thereof
|
|
EP4189072A4
(en)
|
2020-07-29 |
2024-09-18 |
Eureka Therapeutics, Inc. |
T-CELLS AND CHIMERIC STIMULATING RECEPTORS AND USES THEREOF
|